Recent Updates
Recently added Catalysts
GRDN Positive Sentiment

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

Thursday, August 6, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Guardian Pharmacy Services, Inc. reported its financial results for the second quarter of 2026, showing a revenue increase of 2% year-over-year, totaling $351.8 million. The company served approximately 210,000 residents, marking an 8% growth compared to the previous year. Additionally, Guardian raised its full-year guidance, reflecting a positive outlook.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased by 2% year-over-year.
  • Residents served grew by 8% year-over-year.
  • Full-year guidance has been raised, indicating confidence in future performance.

Full Press Release Details

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance. Second Quarter Financial Results Revenue of $351.8 million, up 2% year-over-year. Residents served ended the quarter at approximately 210,000, up 8% year-over-year. Net Income of $22.1 million, inclusive of an $8.5 m

Frequently Asked Questions

What were Guardian Pharmacy's Q2 2026 revenues?

Guardian Pharmacy reported revenues of $351.8 million for Q2 2026.

How many residents did Guardian serve in Q2 2026?

Approximately 210,000 residents were served in Q2 2026.

What was the year-over-year revenue growth?

The revenue growth was 2% year-over-year.

Did Guardian raise its full-year guidance?

Yes, Guardian raised its full-year guidance.

ShareAdd on Google
Tags: GRDN Viatris Investor Conferences Healthcare Guardian Pharmacy Services financial results full-year guidance long-term care pharmacy
Last updated: Aug 6, 2026

Biotech snapshot

Cash runway
$65M liquidity · $0M/mo burn
Low dilution risk